Literature DB >> 6125223

Effects of H2-receptor antagonists and anticholinoceptor drugs on gastric and salivary secretion induced by bethanechol in the anaesthetized dog.

M J Daly, J M Humphray, R Stables.   

Abstract

1 The H2-receptor antagonists, ranitidine and cimetidine, have been compared with atropine and pirenzepine for their effects on gastric acid output, and on salivary secretion from the left parotid gland in the anaesthetized dog. Gastric and salivary secretions were elicited by intravenous infusion of bethanechol. 2 Atropine (0.3-1 microgram/kg) or pirenzepine (3-10 micrograms/kg) reduced both gastric and salivary secretions, pirenzepine showing little evidence of any selectivity for gastric secretion. 3 The H2-receptor antagonists, ranitidine (30-1000 micrograms/kg) and cimetidine (100-3000 micrograms/kg), selectively inhibited gastric secretion and even at relatively high dose levels did not alter salivary volume.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125223      PMCID: PMC2071796          DOI: 10.1111/j.1476-5381.1982.tb09228.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Anticholinergic effects of pirenzepine on the guinea-pig isolated atrium.

Authors:  K Süsskand; K F Sewing
Journal:  Pharmacology       Date:  1979       Impact factor: 2.547

2.  Potential mechanisms of interaction among secretagogues.

Authors:  J D Gardner; M J Jackson; S Batzri; R T Jensen
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

3.  Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.

Authors:  B H Jaup; R W Stockbrügger; G Dotevall
Journal:  Scand J Gastroenterol Suppl       Date:  1980

4.  [Effect of H2 histamine receptor blocking agents on the isolated lower esophageal sphincter (LES) of the rat].

Authors:  G Bertaccini; G Coruzzi
Journal:  Farmaco Sci       Date:  1981-02

5.  Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1981-01       Impact factor: 8.739

6.  The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease.

Authors:  B H Jaup; R Stockbrügger; G Dotevall
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

7.  Inhibition of gastric acid secretion by pirenzepine (LS 519) in man.

Authors:  R Stockbrügger; B Jaup; R Hammer; G Dotevall
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

8.  [Therapy of duodenal ulcer with cimetidine, pirenzipine and placebo: report on a double-blind randomized study].

Authors:  M Giger; J J Gonvers; K B Weber; A Sonnenberg; R Birchler; W Mattle; J R Hofstetter; A L Blum
Journal:  Schweiz Med Wochenschr       Date:  1979-04-21

9.  Muscarinic receptors in the stomach.

Authors:  R Hammer
Journal:  Scand J Gastroenterol Suppl       Date:  1980

10.  Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

  10 in total
  5 in total

1.  Comparative studies of the effects of some antimuscarinic agents on gastric damage and pupillary reflex in the rat.

Authors:  S Daniotti; P Del Soldato
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

Review 2.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 3.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

4.  A study of the effects of saliva stimulation by nizatidine on dry mouth symptoms of primary biliary cirrhosis.

Authors:  Tetsu Kikuchi; Katsuharu Hirano; Takuya Genda; Hironori Tsuzura; Shunsuke Sato; Yoshio Kanemitsu; Yutaka Narita; Katsuyori Iijima; Takafumi Ichida
Journal:  World J Hepatol       Date:  2013-03-27

5.  Does pirenzepine distinguish between 'subtypes' of muscarinic receptors?

Authors:  I Szelenyi
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.